Showing results (1-10 of 80) with videos related to
Sort By:
Pageof 8
Advances in Experimental Medicine and Biology|June 23, 2017
Suppression of Prostate Cancer Metastasis by DPYSL3-Targeted saRNABenyi Li, Changlin LiDrug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy|August 16, 2001
Proteasome inhibitors as potential novel anticancer agentsQ. Ping Dou, Benyi LiFrontiers in Oncology|April 4, 2022
Anti-Androgen Receptor Therapies in Prostate Cancer: A Brief Update and PerspectiveJian Huang, Biyun Lin, Benyi LiAmerican Journal of Clinical and Experimental Urology|July 24, 2020
Natural compound Alternol as a novel therapeutic for prostate cancer treatmentHaixia Xu, Zeqiang Zhou, Benyi LiUrologic Oncology|June 9, 2015
Glycogen synthase kinase-3: a potential preventive target for prostate cancer managementBenyi Li, James Brantley Thrasher, Paul TerranovaJournal of Alzheimer'S Disease : JAD|January 5, 2012
Down-regulation of amyloid-β through AMPK activation by inhibitors of GSK-3β in SH-SY5Y and SH-SY5Y-AβPP695 cellsZhiyou Cai, Benyi Li, Keshen Li, et al.Melanoma Research|July 1, 2025
Upregulation of SFTPC gene expression is associated with disease progression and worse survival outcomes in human skin melanomasYuelong Chai, Jiang Zhao, Xiangwei Wang, et al.Frontiers in Oncology|February 20, 2026
Glycosylated RNAs: discovery and implications in cancer biologyShuai Tang, Ximo Wang, Fangmin Chen, et al.Frontiers in Oncology|February 13, 2023
Jumonji domain-containing protein RIOX2 is overexpressed and associated with worse survival outcomes in prostate cancersChenchen He, Wang Liu, Jiahao Sun, et al.American Journal of Clinical and Experimental Urology|December 27, 2023
Aberrant expression of multiple glycolytic enzyme genes is significantly associated with disease progression and survival outcomes in prostate cancersHaixia Xu, Wang Liu, Chenchen He, et al.Pageof 8